ARTICLE | Clinical News
Amikacin Fosfomycin Inhalation System: Phase II started
January 20, 2014 8:00 AM UTC
Cardeas began the double-blind, placebo-controlled, international Phase II IASIS trial to evaluate Amikacin Fosfomycin Inhalation System delivered twice daily using the eFlow Inline Nebulizer System f...